Search results
Innovative Plant-Based Reagent Start-Up Achieves Breakthrough in Expression of mRNA Enzyme for use...
WFRV 5 Green Bay· 2 days agoTiamat Sciences Corporation, a pioneering plant-based reagent company, proudly announces a significant milestone in the realm of mRNA enzyme production. Tiamat Sciences has ...
Akoya Biosciences Inc (AKYA) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
GuruFocus.com via Yahoo Finance· 3 days agoTotal Revenue: $18.4 million, a 14% decline year-over-year. Reagent Revenue: $7 million, up 23% from the previous year. Instrument Revenue: $4.9 million. Services Revenue: ...
Hades 2’s Forget-Me-Not Mechanic Should Become a Crafting Staple
Game Rant· 19 hours agoFrom the ability to perform (craft) Incantations at the Cauldron in the Crossroads to upgrading...
Insider Sale: Director Christopher Kuebler Sells 4,000 Shares of Waters Corp (WAT)
GuruFocus.com via Yahoo Finance· 19 hours agoThe transaction occurred at a price of $361.64 per share, totaling $1,446,560. Waters Corp...
How to get G Rock in Hades 2, Glassrock locations
VideoGamer.com· 2 days agoLike other Reagents in Hades 2, G Rock (also known as Glassrock) is used in several crafting recipes to make weapons and Aspects. It’s a little hard to...
Akoya Biosciences Q1 Revenues Fall 14 Percent, Miss Expectations due to Weak Instrument Sales
GenomeWeb News· 3 days agoAkoya Biosciences on Monday afternoon reported a 14 percent year-over-year decline in first quarter revenues, primarily due to weakness in instrument placements. As a result of the revenue shortfall ...
How to get Star Dust in Hades 2, Chaos Trials explained
VideoGamer.com· 2 days agoOf all the Reagents you’ll need to hunt down in Hades 2, Star Dust is likely the most elusive and an...
EP4-induced mitochondrial localization and cell migration mediated by CALML6 in human oral squamous...
Nature· 3 days agoEP4 receptor enhances OSCC cell migration through increased Ca2+ signaling, linking to CALML6 and the CaMKK2 pathway. This process promotes mitochondrial function and metastasis, with CaMKK2 emerging as a potential target for OSCC treatment.
Earnings call: Eastman Kodak reports Q1 2024 results
Investing.com· 6 days agoEastman Kodak Company (KODK) has reported its financial results for the first quarter of 2024, showcasing a mixed performance amid a challenging global...
Alpha Teknova: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 4 days ago(TKNO) on Monday reported a loss of $8.1 million in its first quarter. On a per-share basis, the Hollister, California-based company said it had a loss of 20 cents. The maker of reagents ...
